Management of cancer-related pain with intrathecal drug delivery: a systematic review and meta-analysis of clinical studies

C Perruchoud, D Dupoiron, B Papi, A Calabrese… - … : Technology at the …, 2023 - Elsevier
Background Despite increased attention paid to assessment and management, pain
continues to be a prevalent and undertreated symptom in patients with cancer. Intrathecal …

Nonsurgical interventional spine pain procedures: outcomes and complications

CD Whitaker, BK Stone, JA Gregorczyk, D Alsoof… - JBJS …, 2023 - journals.lww.com
Nonsurgical Interventional Spine Pain Procedures: Outcomes a... : JBJS Reviews
Nonsurgical Interventional Spine Pain Procedures: Outcomes and Complications : JBJS …

Endogenous opiates and behavior: 2017

RJ Bodnar - Peptides, 2020 - Elsevier
This paper is the fortieth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Optimizing initial intrathecal drug ratio for refractory cancer-related pain for early pain relief. A retrospective monocentric study

D Dupoiron, D Leblanc, S Demelliez-Merceron… - Pain …, 2019 - academic.oup.com
Objective Intrathecal (IT) drug delivery has shown its efficiency in treating refractory cancer
pain, but switching opioids from the systemic to the intrathecal route is a challenging phase …

Evaluation of fixed intrathecal bupivacaine infusion doses in the oncologic population

GH Chen, MA Spiegel, YC Magram… - … : Technology at the …, 2020 - Wiley Online Library
Objectives Intrathecal drug delivery systems (IDDS) are an important method of pain control
for patients with refractory oncologic pain. Local anesthetics such as bupivacaine have been …

Efficacy of epidural analgesia for intractable cancer pain: A systematic review

YL Hsieh, HY Chen, CR Lin, CF Wang - Pain Practice, 2023 - Wiley Online Library
Background Epidural analgesia is a common technique for managing perioperative and
obstetric pain. Patients with cancer who cannot tolerate opioids or not responding to …

Effects of an Intrathecal Drug Delivery System Connected to a Subcutaneous Port on Pain, Mood and Quality of Life in End Stage Cancer Patients: An Observational …

M Giglio, A Preziosa, R Mele, N Brienza… - Cancer …, 2022 - journals.sagepub.com
Background In cancer patients with limited life expectancy, an implant of an intrathecal (IT)
drug delivery system connected to a subcutaneous port (IDDS-SP) has been proposed as a …

Cost-Effectiveness and Cost–Utility Analyses in Thailand of Continuous Intrathecal Morphine Infusion Compared with Conventional Therapy in Cancer Pain: A 10-year …

A Thepsuwan, N Tontisirin, P Euasobhon… - Canadian Journal of …, 2023 - Taylor & Francis
Background Because of the high initial cost of intrathecal drug delivery (ITDD) therapy, this
study investigated the cost-effectiveness and cost–utility of ITDD therapy in refractory cancer …

Differences in efficacy and safety between intrathecal infusion devices in cancer pain

D Díaz‐Rodríguez, IM Fontán‐Atalaya… - Pain …, 2024 - Wiley Online Library
Background Intrathecal infusion therapy is widely accepted for cancer pain patients when
conventional analgesic treatments are not sufficient. There are different types of devices for …

Evaluation of an intrathecal drug delivery protocol leads to rapid reduction of systemic opioids in the oncological population

MA Spiegel, GH Chen, AC Solla… - Journal of Palliative …, 2021 - liebertpub.com
Objective: The article that follows is purposed at demonstrating how IT opioid plus
bupivacaine achieves sustained acceptable pain relief while simultaneously rapidly …